RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
West Pharmaceutical Services Stock

West Pharmaceutical Services P/S 2025

West Pharmaceutical Services P/S

5.46

Ticker

WST

ISIN

US9553061055

WKN

864330

As of Feb 18, 2025, West Pharmaceutical Services's P/S ratio stood at 5.46, a -35.54% change from the 8.47 P/S ratio recorded in the previous year.

The West Pharmaceutical Services P/S history

West Pharmaceutical Services Aktienanalyse

What does West Pharmaceutical Services do?

West Pharmaceutical Services Inc. is a leading company in the development and manufacturing of innovative solutions for drug delivery and medical devices. The company has been in the market for over 100 years and is headquartered in Exton, Pennsylvania, USA. West operates in more than 50 countries worldwide and employs over 9,000 employees. The history of West Pharmaceutical Services begins in 1923, when Herman O. West founded the company in Philadelphia. Initially, West primarily produced rubber seals for canning jars and bottle closures. In the 1930s, West entered the production of plastic parts used in products such as tube radios. In the mid-1950s, West began to venture into the production of medical devices and accessories, such as syringe stoppers. Since then, the company has continuously expanded its product range and is now a leading provider of pharmaceutical delivery solutions. West is divided into three business segments: Healthcare Delivery Systems (HDS), Pharmaceutical Packaging Systems (PPS), and Contract Manufacturing Organization (CMO). The Healthcare Delivery Systems (HDS) segment specializes in the development and manufacturing of devices and systems for drug delivery. This includes syringes, injection devices, pen systems, nasal and inhalation devices. These products are developed in collaboration with various pharmaceutical companies to simplify and improve medication delivery. West has also developed many patented products, such as the "SmartDose" system, which enables accurate dosage delivery. The Pharmaceutical Packaging Systems (PPS) segment offers packaging solutions for pharmaceuticals. This includes injection vials, caps, and closures made of glass or plastic. PPS has also developed specialized packaging solutions, such as the "Ready Pack" solution, which packages sterile products in a safe and user-friendly environment. Another example is the "Westar UD" system, which allows for accurate and safe dosing of medications in ampoules. The Contract Manufacturing Organization (CMO) segment offers customized services, including design and development of packaging solutions and manufacturing of pharmaceuticals and medical devices. CMO manufacturing services include development, manufacturing, filling, and packaging of sterility products. West has a wide customer base in the pharmaceutical and biotech industry. The company works closely with its customers to develop customized solutions that meet their specific needs. West also has strong partnerships with other leading companies in the industry, such as Merck or Daikyo. Overall, West Pharmaceutical Services is distinguished by its high focus on quality and safety. The company places great emphasis on compliance with regulatory requirements and the use of safety-conscious manufacturing technologies. West also has its own quality control department, which ensures the high quality of its products and satisfies its customers. In summary, West Pharmaceutical Services is a leading provider of pharmaceutical delivery solutions and packaging solutions. With a wide portfolio of innovative products and services tailored to meet customer needs, West can provide safe and effective solutions to its customers worldwide. West Pharmaceutical Services ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding West Pharmaceutical Services's P/S Ratio

West Pharmaceutical Services's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing West Pharmaceutical Services's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating West Pharmaceutical Services's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in West Pharmaceutical Services’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about West Pharmaceutical Services stock

What is the price-to-earnings ratio of West Pharmaceutical Services?

The price-earnings ratio of West Pharmaceutical Services is currently 5.46.

How has the price-earnings ratio of West Pharmaceutical Services changed compared to last year?

The price-to-earnings ratio of West Pharmaceutical Services has increased by -35.54% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of West Pharmaceutical Services high compared to other companies?

Yes, the price-to-earnings ratio of West Pharmaceutical Services is high compared to other companies.

How does an increase in the price-earnings ratio of West Pharmaceutical Services affect the company?

An increase in the price-earnings ratio of West Pharmaceutical Services would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of West Pharmaceutical Services affect the company?

A decrease in the price-earnings ratio of West Pharmaceutical Services would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of West Pharmaceutical Services?

Some factors that influence the price-earnings ratio of West Pharmaceutical Services are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does West Pharmaceutical Services pay?

Over the past 12 months, West Pharmaceutical Services paid a dividend of 0.77 USD . This corresponds to a dividend yield of about 0.36 %. For the coming 12 months, West Pharmaceutical Services is expected to pay a dividend of 0.92 USD.

What is the dividend yield of West Pharmaceutical Services?

The current dividend yield of West Pharmaceutical Services is 0.36 %.

When does West Pharmaceutical Services pay dividends?

West Pharmaceutical Services pays a quarterly dividend. This is distributed in the months of May, August, December, March.

How secure is the dividend of West Pharmaceutical Services?

West Pharmaceutical Services paid dividends every year for the past 54 years.

What is the dividend of West Pharmaceutical Services?

For the upcoming 12 months, dividends amounting to 0.92 USD are expected. This corresponds to a dividend yield of 0.43 %.

In which sector is West Pharmaceutical Services located?

West Pharmaceutical Services is assigned to the 'Health' sector.

Wann musste ich die Aktien von West Pharmaceutical Services kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of West Pharmaceutical Services from 2/11/2025 amounting to 0.21 USD, you needed to have the stock in your portfolio before the ex-date on 2/7/2025.

When did West Pharmaceutical Services pay the last dividend?

The last dividend was paid out on 2/11/2025.

What was the dividend of West Pharmaceutical Services in the year 2024?

In the year 2024, West Pharmaceutical Services distributed 0.77 USD as dividends.

In which currency does West Pharmaceutical Services pay out the dividend?

The dividends of West Pharmaceutical Services are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The West Pharmaceutical Services stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von West Pharmaceutical Services

Our stock analysis for West Pharmaceutical Services Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of West Pharmaceutical Services Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.